GalenusRx (GRx) is the worlds most advanced medication safety organization. GRx flips the reactive model of pharmacovigilance with proactive, predictive, medication safety technology. We streamline the process of forecasting risk of simultaneous multi-drug interactions and adverse drug events using real-world data and predictive analytics identifying safety issues before new drugs enter the market, virtually.
Our APPRAISE ADE Forecasting solution uses quasi-mechanistic, predictive algorithms to derive actionable, context-specific insights to improve drug safety across the entie pre-and post drug approval lifecycle. These pre-emptive insights are derived from our proprietary assessment of simultanous multi-drug, drug-gene and drug-disease interactions.
Our APPRAISE Personalized Comprehensive Polypharmacy Engagement solution leverages highly trained and certified Precision Clinical Pharmacists in community settings to support the successful launch and post-launch of new drug entities into the real world. By virtually adding the new drug to individual patients' medication regimens, considering their existing prescription, OTCs, herbals, recreational drugs, etc., Precision Clinical Pharmacists optimize their medication regimen before starting therapy. Results include the avoidance of preventable adverse drug events, reduced healthcare costs and improved lives.
Learn more! Visit www.galenusrx.com and contact us today: Orsula V. Knowlton, PharmD, MBA ovknowlton@galenusrx.com |+1 215-680-8983 or info@galenusrx.com| 855-GalenusRx (425-3687)